AI Article Synopsis
- A new anti-alcoholic drug, litonit, has shown significant effectiveness in reducing alcohol addiction and creating a lasting aversive response to alcohol.
- Litonit is characterized by low toxicity and good tolerance in patients, making it a safer option for those struggling with alcohol dependency.
- Long-term use of litonit does not lead to liver or kidney disorders, which is a common concern with many medications.
Article Abstract
Clinical data are presented on a new anti-alcoholic drug, litonit. A substantial reduction in the pathological addiction to alcohol takes place under the effect of litonit, and a stable aversive reaction to alcohol develops. The new drug is distinguished by its low toxicity, good tolerance, and its failure to cause disorders of the liver and kidneys even after chronic administration.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
litonit evaluation
4
evaluation clinical
4
clinical effectiveness
4
effectiveness clinical
4
clinical data
4
data presented
4
presented anti-alcoholic
4
anti-alcoholic drug
4
drug litonit
4
litonit substantial
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!